FDA Considering New Regulatory Approach for CBD; Raises Concerns Over CBD in Foods, Supplements
The U.S. Food and Drug Administration (FDA) has decided that cannabidiol (CBD) products will not be regulated as a food or supplement, rather, a new approach will be developed for the increasingly popular substance. The agency has also denied three consumer petitions requesting that FDA allow the marketing of CBD products as dietary supplements, given the agency does not intend to regulate CBD as a supplement or food.
FDA came to the conclusion that a new regulatory pathway is required for CBD products after an extensive review by a high-level internal working group, chaired by FDA Principal Deputy Commissioner Janet Woodcock, M.D. The agency expresses that it is willing to work with U.S. Congress on the matter of forging a new framework for CBD oversight in food and supplements.